• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

韩国版广泛性焦虑障碍量表(GAD-7)和广泛性焦虑障碍简易量表(GAD-2)的心理测量特性及临床效用

The Psychometric Properties and Clinical Utility of the Korean Version of GAD-7 and GAD-2.

作者信息

Ahn Jung-Kwang, Kim Yeseul, Choi Kee-Hong

机构信息

Department of Psychology, Korea University Mind Health Institute, Korea University, Seoul, South Korea.

Department of Psychology, Korea University, Seoul, South Korea.

出版信息

Front Psychiatry. 2019 Mar 18;10:127. doi: 10.3389/fpsyt.2019.00127. eCollection 2019.

DOI:10.3389/fpsyt.2019.00127
PMID:30936840
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC6431620/
Abstract

Generalized anxiety disorder (GAD) is a common but serious form of anxiety disorder. Despite this, the rate of GAD recognition in primary care remains low in both Western and Eastern countries. The GAD-7 and GAD-2 were developed to efficiently identify people with GAD, and their reliability and validity have been well-documented in Western countries. The GAD-7 and GAD-2 have also been widely utilized to screen for other anxiety disorders; however, their diagnostic utility has not been fully justified with empirical support, especially in East Asian samples. In this study, we examined the diagnostic sensitivity and specificity of these screening tools for identifying individuals with GAD or other anxiety disorders, and recommended screening cutoff scores for GAD and other anxiety disorders for use in Korea. Based on the rigorous standard suggested by the Quality Assessment of Diagnostic Accuracy Studies-2, a total of 1,157 participants randomly recruited from the community completed the GAD-7, GAD-2, and other anxiety and depression measures in a counter-balanced order. All participants were assessed, and their psychiatric diagnosis confirmed through a structured clinical interview conducted by independent clinicians blinded to the results of the self-report questionnaires. The GAD-7 and GAD-2 both showed excellent reliability and validity. Notably, both the GAD-7 and GAD-2 demonstrated acceptable diagnostic accuracy in detecting GAD with similar recommended cut-off scores as those reported in Western countries, but unacceptable diagnostic accuracy for other anxiety disorders. We conclude that given their brevity, the GAD-7 and GAD-2 can be well-utilized to identify people with GAD for preventative evaluation and treatment in Korea. Use of the GAD-7 and GAD-2 for screening other anxiety disorders should be cautioned.

摘要

广泛性焦虑障碍(GAD)是一种常见但严重的焦虑症形式。尽管如此,在西方国家和东方国家,初级保健中对GAD的识别率仍然很低。GAD-7和GAD-2旨在有效识别患有GAD的人,其可靠性和有效性在西方国家已有充分记录。GAD-7和GAD-2也被广泛用于筛查其他焦虑症;然而,它们的诊断效用尚未得到充分的实证支持,尤其是在东亚样本中。在本研究中,我们检验了这些筛查工具在识别患有GAD或其他焦虑症个体时的诊断敏感性和特异性,并推荐了用于韩国的GAD和其他焦虑症的筛查临界分数。基于诊断准确性研究质量评估-2提出的严格标准,从社区随机招募的1157名参与者以平衡顺序完成了GAD-7、GAD-2以及其他焦虑和抑郁测量。所有参与者都接受了评估,并且通过由对自我报告问卷结果不知情的独立临床医生进行的结构化临床访谈确认了他们的精神诊断。GAD-7和GAD-2均显示出出色的可靠性和有效性。值得注意的是,GAD-7和GAD-2在检测GAD时都表现出可接受的诊断准确性,推荐的临界分数与西方国家报告的相似,但在检测其他焦虑症时诊断准确性不可接受。我们得出结论,鉴于其简洁性,GAD-7和GAD-2可很好地用于在韩国识别患有GAD的人以进行预防性评估和治疗。应谨慎使用GAD-7和GAD-2筛查其他焦虑症。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e38/6431620/e19bae279991/fpsyt-10-00127-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e38/6431620/e19bae279991/fpsyt-10-00127-g0001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/4e38/6431620/e19bae279991/fpsyt-10-00127-g0001.jpg

相似文献

1
The Psychometric Properties and Clinical Utility of the Korean Version of GAD-7 and GAD-2.韩国版广泛性焦虑障碍量表(GAD-7)和广泛性焦虑障碍简易量表(GAD-2)的心理测量特性及临床效用
Front Psychiatry. 2019 Mar 18;10:127. doi: 10.3389/fpsyt.2019.00127. eCollection 2019.
2
Validity of the Generalized Anxiety Disorder-7 scale in an acute psychiatric sample.广泛性焦虑障碍 7 项量表在急性精神病样本中的有效性。
Clin Psychol Psychother. 2013 Sep-Oct;20(5):456-64. doi: 10.1002/cpp.1802. Epub 2012 May 17.
3
[Sensitivity and specificity of the worry and anxiety questionnaire (WAQ) in a sample of health-care users in the province of Quebec].[魁北克省医疗保健用户样本中担忧与焦虑问卷(WAQ)的敏感性和特异性]
Encephale. 2008 Jun;34(3):240-8. doi: 10.1016/j.encep.2007.01.008. Epub 2007 Oct 24.
4
Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis.使用广泛性焦虑障碍量表-7(GAD-7)和广泛性焦虑障碍量表-2(GAD-2)筛查焦虑症:一项系统评价与诊断性荟萃分析
Gen Hosp Psychiatry. 2016 Mar-Apr;39:24-31. doi: 10.1016/j.genhosppsych.2015.11.005. Epub 2015 Nov 18.
5
Beyond generalized anxiety disorder: psychometric properties of the GAD-7 in a heterogeneous psychiatric sample.超越广泛性焦虑障碍:GAD-7 在异质精神科样本中的心理测量特性。
J Anxiety Disord. 2014 Aug;28(6):547-52. doi: 10.1016/j.janxdis.2014.06.002. Epub 2014 Jun 14.
6
The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients.广泛性焦虑障碍筛查量表(GAD-7)和医院焦虑抑郁量表(HADS-A)中的焦虑模块作为癌症患者广泛性焦虑障碍的筛查工具。
Psychooncology. 2018 Jun;27(6):1509-1516. doi: 10.1002/pon.4681. Epub 2018 Mar 30.
7
Validation of the generalized anxiety disorder-7 in people with epilepsy: a MEPSY study.癫痫患者广泛性焦虑障碍 7 项量表的验证:MEPSY 研究。
Epilepsy Behav. 2014 Jun;35:59-63. doi: 10.1016/j.yebeh.2014.04.005. Epub 2014 May 4.
8
Diagnostic and Clinical Utility of the GAD-2 for Screening Anxiety Symptoms in Individuals With Multiple Sclerosis.用于筛查多发性硬化症患者焦虑症状的 GAD-2 的诊断和临床效用。
Arch Phys Med Rehabil. 2018 Oct;99(10):2045-2049. doi: 10.1016/j.apmr.2018.05.029. Epub 2018 Jun 30.
9
Rapid detection of generalized anxiety disorder and major depression in epilepsy: Validation of the GAD-7 as a complementary tool to the NDDI-E in a French sample.癫痫患者中广泛性焦虑障碍和重度抑郁症的快速检测:在法国样本中验证GAD-7作为NDDI-E补充工具的有效性。
Epilepsy Behav. 2016 Apr;57(Pt A):211-216. doi: 10.1016/j.yebeh.2016.02.015. Epub 2016 Mar 16.
10
Accuracy of anxiety and depression screening tools in heart transplant recipients.心脏移植受者焦虑和抑郁筛查工具的准确性
Appl Nurs Res. 2016 Nov;32:177-181. doi: 10.1016/j.apnr.2016.07.015. Epub 2016 Aug 5.

引用本文的文献

1
Depressive and anxiety symptoms mediate the relationship between family support and alcohol relapse in transplant recipients with alcohol-associated liver disease.抑郁和焦虑症状在酒精相关性肝病移植受者中调节家庭支持与酒精复发之间的关系。
Sci Rep. 2025 Aug 5;15(1):28546. doi: 10.1038/s41598-025-14345-w.
2
Screening mental health risks for adolescents in South Korea.韩国青少年心理健康风险筛查
Front Psychol. 2025 Jul 16;16:1589136. doi: 10.3389/fpsyg.2025.1589136. eCollection 2025.
3
Psychometric Properties of the GAD-7 among College Students: Reliability, Validity, Factor Structure, and Measurement Invariance.

本文引用的文献

1
The Generalized Anxiety Disorder Screener (GAD-7) and the anxiety module of the Hospital and Depression Scale (HADS-A) as screening tools for generalized anxiety disorder among cancer patients.广泛性焦虑障碍筛查量表(GAD-7)和医院焦虑抑郁量表(HADS-A)中的焦虑模块作为癌症患者广泛性焦虑障碍的筛查工具。
Psychooncology. 2018 Jun;27(6):1509-1516. doi: 10.1002/pon.4681. Epub 2018 Mar 30.
2
A systematic review of reviews on the prevalence of anxiety disorders in adult populations.一项关于成年人群体中焦虑障碍患病率的系统综述。
Brain Behav. 2016 Jun 5;6(7):e00497. doi: 10.1002/brb3.497. eCollection 2016 Jul.
3
Screening for anxiety disorders with the GAD-7 and GAD-2: a systematic review and diagnostic metaanalysis.
大学生中广泛性焦虑障碍量表-7(GAD-7)的心理测量特性:信度、效度、因子结构和测量不变性
Transl Issues Psychol Sci. 2023 Dec 14. doi: 10.1037/tps0000382.
4
The Arabic Version of the Patient Health Questionnaire-2 (PHQ-2): Psychometric Evaluation Among Mothers of Children With Intellectual Disabilities.患者健康问卷-2(PHQ-2)阿拉伯语版本:对智障儿童母亲的心理测量评估
Nurs Res Pract. 2025 Jul 10;2025:9934710. doi: 10.1155/nrp/9934710. eCollection 2025.
5
Clinical utility of the GAD-7 for detecting generalized anxiety in Quechua indigenous people.广泛性焦虑障碍量表-7(GAD-7)在检测克丘亚族原住民广泛性焦虑方面的临床效用。
Front Psychiatry. 2025 May 30;16:1565895. doi: 10.3389/fpsyt.2025.1565895. eCollection 2025.
6
Characteristics and Prevalence of Sequelae after COVID-19: A Longitudinal Cohort Study.新冠病毒病后遗症的特征与患病率:一项纵向队列研究
Infect Chemother. 2025 Mar;57(1):72-80. doi: 10.3947/ic.2024.0090.
7
Psychometric evaluation and community norms of the GAD-7, based on a representative German sample.基于具有代表性的德国样本对广泛性焦虑障碍量表(GAD-7)进行心理测量评估及建立社区常模。
Front Psychol. 2025 Mar 20;16:1526181. doi: 10.3389/fpsyg.2025.1526181. eCollection 2025.
8
Generalized Anxiety Disorder 7-item (GAD-7) and 2-item (GAD-2) scales for detecting anxiety disorders in adults.用于检测成人焦虑症的广泛性焦虑障碍7项(GAD - 7)和2项(GAD - 2)量表。
Cochrane Database Syst Rev. 2025 Mar 25;3(3):CD015455. doi: 10.1002/14651858.CD015455.
9
A Brief Cognitive Behavioral Therapy-Based Digital Intervention for Reducing Hazardous Alcohol Use in South Korea: Development and Prospective Pilot Study.一项基于认知行为疗法的简短数字干预措施,用于减少韩国的有害饮酒行为:开发与前瞻性试点研究。
JMIR Form Res. 2025 Mar 19;9:e64459. doi: 10.2196/64459.
10
Internal Validity and Reliability of the GAD-7 Test in Latin America.广泛性焦虑障碍7项量表(GAD-7)测试在拉丁美洲的内部效度和信度
Chronic Stress (Thousand Oaks). 2025 Mar 11;9:24705470251315260. doi: 10.1177/24705470251315260. eCollection 2025 Jan-Dec.
使用广泛性焦虑障碍量表-7(GAD-7)和广泛性焦虑障碍量表-2(GAD-2)筛查焦虑症:一项系统评价与诊断性荟萃分析
Gen Hosp Psychiatry. 2016 Mar-Apr;39:24-31. doi: 10.1016/j.genhosppsych.2015.11.005. Epub 2015 Nov 18.
4
Validation of the Generalized Anxiety Disorder-7 (GAD-7) and GAD-2 in patients with migraine.偏头痛患者中广泛性焦虑障碍-7(GAD-7)和广泛性焦虑障碍-2(GAD-2)的验证
J Headache Pain. 2015;16:97. doi: 10.1186/s10194-015-0583-8. Epub 2015 Nov 23.
5
Cultural-based biases of the GAD-7.广泛性焦虑障碍量表(GAD-7)的文化偏倚。
J Anxiety Disord. 2015 Apr;31:38-42. doi: 10.1016/j.janxdis.2015.01.005. Epub 2015 Feb 7.
6
Prevalence of anxiety disorders among Finnish primary care high utilizers and validation of Finnish translation of GAD-7 and GAD-2 screening tools.芬兰初级保健高利用率人群中焦虑症的患病率以及广泛性焦虑障碍筛查量表7项版(GAD-7)和广泛性焦虑障碍筛查量表2项版(GAD-2)芬兰语翻译版的验证
Scand J Prim Health Care. 2014 Jun;32(2):78-83. doi: 10.3109/02813432.2014.920597. Epub 2014 Jun 12.
7
Validation of the generalized anxiety disorder-7 in people with epilepsy: a MEPSY study.癫痫患者广泛性焦虑障碍 7 项量表的验证:MEPSY 研究。
Epilepsy Behav. 2014 Jun;35:59-63. doi: 10.1016/j.yebeh.2014.04.005. Epub 2014 May 4.
8
The assessment of generalized anxiety disorder: psychometric validation of the Spanish version of the self-administered GAD-2 scale in daily medical practice.广泛性焦虑障碍的评估:在日常医疗实践中,自填式 GAD-2 量表的西班牙版本的心理测量学验证。
Health Qual Life Outcomes. 2012 Sep 19;10:114. doi: 10.1186/1477-7525-10-114.
9
QUADAS-2: a revised tool for the quality assessment of diagnostic accuracy studies.QUADAS-2:用于诊断准确性研究质量评估的修订工具。
Ann Intern Med. 2011 Oct 18;155(8):529-36. doi: 10.7326/0003-4819-155-8-201110180-00009.
10
Rates of detection of mood and anxiety disorders in primary care: a descriptive, cross-sectional study.基层医疗中情绪和焦虑障碍的检出率:一项描述性横断面研究。
Prim Care Companion CNS Disord. 2011;13(2). doi: 10.4088/PCC.10m01013.